Group One Trading’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.94M | Buy |
140,166
+116,958
| +504% | +$2.63M | 0.01% | 1721 |
|
|
2025
Q4 | $534K | Buy |
+23,208
| New | +$763K | ﹤0.01% | 3436 |
|
|
2025
Q3 | – | Sell |
-5,559
| Closed | -$167K | – | 9012 |
|
|
2025
Q2 | $202K | Buy |
+5,559
| New | +$200K | ﹤0.01% | 4333 |
|
|
2025
Q1 | – | Sell |
-3,610
| Closed | -$150K | – | 8240 |
|
|
2024
Q4 | $152K | Sell |
3,610
-6,349
| -64% | -$315K | ﹤0.01% | 4154 |
|
|
2024
Q3 | $553K | Sell |
9,959
-511
| -5% | -$26K | ﹤0.01% | 2776 |
|
|
2024
Q2 | $430K | Buy |
10,470
+1,335
| +15% | +$57K | ﹤0.01% | 2704 |
|
|
2024
Q1 | $427K | Buy |
9,135
+2,851
| +45% | +$134K | ﹤0.01% | 2890 |
|
|
2023
Q4 | $301K | Buy |
6,284
+591
| +10% | +$22.9K | ﹤0.01% | 3503 |
|
|
2023
Q3 | $203K | Buy |
+5,693
| New | +$226K | ﹤0.01% | 3785 |
|
|
2023
Q2 | – | Sell |
-8,648
| Closed | -$401K | – | 8110 |
|
|
2023
Q1 | $347K | Buy |
+8,648
| New | +$371K | ﹤0.01% | 3125 |
|
|
2022
Q1 | – | Sell |
-130
| Closed | -$11K | – | 8563 |
|
|
2021
Q4 | $11K | Buy |
130
+100
| +333% | +$8.14K | ﹤0.01% | 7314 |
|
|
2021
Q3 | $3K | Sell |
30
-871
| -97% | -$78.7K | ﹤0.01% | 7882 |
|
|
2021
Q2 | $86K | Buy |
901
+804
| +829% | +$83.8K | ﹤0.01% | 6106 |
|
|
2021
Q1 | $11K | Buy |
+97
| New | +$13.2K | ﹤0.01% | 7022 |
|
|
2020
Q3 | – | Sell |
-101
| Closed | -$8K | – | 6474 |
|
|
2020
Q2 | $8K | Sell |
101
-1,077
| -91% | -$71.3K | ﹤0.01% | 5223 |
|
|
2020
Q1 | $52K | Buy |
1,178
+875
| +289% | +$45.4K | ﹤0.01% | 3689 |
|
|
2019
Q4 | $13K | Buy |
303
+251
| +483% | +$10.4K | ﹤0.01% | 4519 |
|
|
2019
Q3 | $2K | Hold |
52
| – | – | ﹤0.01% | 4923 |
|
|
2019
Q2 | $3K | Buy |
+52
| New | +$3.31K | ﹤0.01% | 4704 |
|
|
2019
Q1 | – | Sell |
-7
| Closed | -$400 | – | 5271 |
|
|
2018
Q4 | $0 | Buy |
+7
| New | +$383 | ﹤0.01% | 5313 |
|
|
2018
Q3 | – | Sell |
-829
| Closed | -$67.4K | – | 5539 |
|
|
2018
Q2 | $64K | Buy |
+829
| New | +$53.5K | ﹤0.01% | 3821 |
|
|
2017
Q1 | – | Sell |
-1,009
| Closed | -$76.9K | – | 4933 |
|
|
2016
Q4 | $71K | Buy |
1,009
+573
| +131% | +$40.7K | ﹤0.01% | 3044 |
|
|
2016
Q3 | $31K | Sell |
436
-5,689
| -93% | -$363K | ﹤0.01% | 3600 |
|
|
2016
Q2 | $300K | Buy |
6,125
+3,151
| +106% | +$204K | ﹤0.01% | 2122 |
|
|
2016
Q1 | $188K | Buy |
+2,974
| New | +$195K | ﹤0.01% | 2360 |
|
|
2015
Q1 | – | Sell |
-716
| Closed | -$39.8K | – | 5095 |
|
|
2014
Q4 | $31K | Sell |
716
-439
| -38% | -$20.1K | ﹤0.01% | 3707 |
|
|
2014
Q3 | $65K | Buy |
1,155
+755
| +189% | +$38K | ﹤0.01% | 3351 |
|
|
2014
Q2 | $18K | Buy |
+400
| New | +$16.5K | ﹤0.01% | 4232 |
|
Other funds holding RARE
VPM
VCM
RI
SI
BG
Group One Trading's RARE Position: Q1 2026 in Review
Group One Trading increased its Ultragenyx Pharmaceutical (RARE) stake by 504% in Q1 2026, buying an estimated $2.63M and bringing the position to 140,166 shares worth $2.94M. The position accounts for 0.01% of the portfolio, ranked #1721.
Group One Trading first reported a position in RARE in Q2 2014 and has held it in 28 quarters since. 296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.
- Group One Trading held 140,166 shares of Ultragenyx Pharmaceutical worth $2.94M as of Q1 2026.
- Group One Trading bought 116,958 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $2.63M.
- Ultragenyx Pharmaceutical made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1721 holding.
- Group One Trading first reported a position in Ultragenyx Pharmaceutical in Q2 2014 and has held it in 28 quarters since.
- 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.